Description:
Diverticular Treatment: Introduction
• Diverticular is one of the foremost common gastrointestinal conditions affecting the overall population in the world
• An estimated 2.5 million people suffer from diverticular disease in the U.S. every year. Clinical signs of diverticulosis range from asymptomatic diverticulosis to complicated diverticulitis.
• Treatment for symptomatic diverticular disease is essentially based on symptoms. Conventional treatment includes fiber, bowel rest, antibiotics, pain control, and medical surgery for selected cases. The research discusses recent advances in the medical treatment of diverticulitis diseases, such as the utilization of mesalamine, rifaximin, and probiotics, as our understanding of the disease evolves.
• Diverticular disease is a digestive condition that results in the formation of sacs or small bulges within the wall of the large intestine. These sacs are often formed anywhere within the colon, but it's majorly found within the sigmoid flexure.
• Diverticular disease is often caused by numerous factors such as low fiber diet, lack of physical exercise, and certain medications such as anti-inflammatory drugs, lack of vitamin D, obesity, and smoking. Symptoms of diverticular disease range from uncomplicated or complicated diverticulitis to chronic abdominal pain, bloating, and irregular bowel habits. The pathogenesis and management of diverticulosis and diverticular disease remain questionable; however, new hypotheses and perceptions are changing how we treat diverticular disease to enhance symptoms and stop serious complications.
Report Overview:
https://www.transparencymarketresearch.com/diverticular-treatment-m...
Key Drivers, Restraints, and Opportunities of Diverticular Treatment Market
• Rise in cases of obesity and drug intake drive the diverticulitis market. The specific reason behind diverticular is smoking cigarettes, lack of exercise, a diet high in animal fat and low in fiber, and excessive use of certain medication such as steroids, opioids and NSAIDs, which is estimated to boost the diverticular market
• Continuous clinical trials happening in rare diseases and increased demand for medicines for the treatment of digestive disorders are projected to drive the global diverticular treatment market during the forecast period. However, a lack of patient awareness in developing countries and stringent FDA guidelines for the approval of the latest treatment or medicines may hamper the worldwide diverticular market. Furthermore, the global diverticular treatment market is majorly driven by the growing prevalence of obesity, rising geriatric population resulting in a rise in the patient population, increase in cigarette smoking population, and growing mass young population inclined toward a sedentary lifestyle. Moreover, government activities and support, rising demand for advanced treatment, and rise in number of market players offering newer products are estimated to drive the market.
North America to Dominate the Global Diverticular Treatment Market
• The diverticular disease market in North America is estimated to expand at a rapid pace due to an increase in number of passive smokers, coupled with a rise in the geriatric population is in the region
• Rise in demand for medical service and technologically advanced treatment and products alongside rising government support is projected to further propel the diverticular treatment market in North America
• Europe is expected to be the second-largest market for diverticular treatment and hold a healthy share of the global diverticular treatment market. The market in Europe is anticipated to expand at a healthy CAGR during the forecast period due to the availability of newer and advanced treatment facilities and rising skilled medical professionals besides the growing need for better healthcare infrastructure.
• Increase in geriatric population and standard of living is driving the diverticular treatment market
• Rising awareness about health and availability of the latest treatment methods drive the market in Asia Pacific. China is a rapidly expanding market in the region due to an increase in the geriatric population in the country. Increasing medical expenditure and standard of living is driving the diverticular treatment market in Asia Pacific.
Request For Custom Research:
https://www.transparencymarketresearch.com/sample/sample.php?flag=C...

Key Players of Diverticular Treatment Market
Some of the key players in the diverticular treatment market are
• Sucampo Pharmaceuticals, Inc.
• Valeant Pharmaceuticals International, Inc.
• Abbott Laboratories
• Synergy Pharmaceuticals, Inc.
• Ardelyx, Inc.
• Astellas Pharma Inc.
• Novartis AG
Global Diverticular Treatment Market: Research Scope
Diverticular Treatment Market, by Type
• Diverticulosis
• Diverticulitis
• Diverticular bleeding
Diverticular Treatment Market, by Treatment
• Medication
o Antibiotics
o Penicillin
o Others
• Surgery
• Supportive Care
Diverticular Treatment Market, by Distribution Channel
• Hospital Pharmacy
• Retail pharmacy
• Online pharmacy
• Others
Diverticular Treatment Market, by Region
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia & New Zealand
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Rest of Latin America
• Middle East & Africa
o GCC Countries
o South Africa
o Rest of Middle East & Africa
Pre Book:
https://www.transparencymarketresearch.com/checkout.php?rep_id=8196...
About Us:
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact us:
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/